Cleared Traditional

K083518 - ACL ACUSTAR, HEMOSIL ACUSTAR D-DIMER, HEMOSIL ACUSTAR D-DIMER CONTROLS

K083518 is an FDA 510(k) clearance for ACL ACUSTAR, manufactured by Instrumentation Laboratory CO. The device is a Class 2 Hematology device with product code JPA cleared through the Traditional 510(k) pathway after a 107-day FDA review.

K083518 · Instrumentation Laboratory CO · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2009
Decision
107d
Days
Class 2
Risk

K083518 is an FDA 510(k) clearance for the ACL ACUSTAR, HEMOSIL ACUSTAR D-DIMER, HEMOSIL ACUSTAR D-DIMER CONTROLS. Classified as System, Multipurpose For In Vitro Coagulation Studies (product code JPA), Class II - Special Controls.

Submitted by Instrumentation Laboratory CO (Bedford, US). The FDA issued a Cleared decision on March 13, 2009 after a review of 107 days - within the typical 510(k) review window.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5425 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all Instrumentation Laboratory CO devices

FDA 510(k) Submission Details - K083518

510(k) Number K083518 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 26, 2008
Decision Date March 13, 2009
Days to Decision 107 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
6d faster than avg
Panel avg: 113d · This submission: 107d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JPA Device Classification - Class 2, Special Controls

Product Code JPA System, Multipurpose For In Vitro Coagulation Studies
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - JPA System, Multipurpose For In Vitro Coagulation Studies

All 153
Devices cleared under the same product code (JPA) and FDA review panel - the closest regulatory comparables to K083518.
Sysmex Automated Blood Coagulation Analyzer CS-2100i
K151259 · Siemens Healthcare Diagnostics Products GmbH · Jan 2016
STA COMPACT MAX
K130090 · Diagnostica Stago, Incorporated · Feb 2013
STA COMPACT AUTOMATED MULTI-PARAMETRIC ANALYZER
K093167 · Diagnostica Stago, Inc. · Dec 2009
BERICHROM HEPARIN LMW CALIBRATOR, BERICHROM HEPARIN LMW CONTROL 1, AND BERICHROM HEPARIN LMW CONTROL 2
K083159 · Siemens Healthcare Diagnostics · Jan 2009
BERICHROM HEPARIN UF CALIBRATOR, BERICHROM HEPARIN UF CONTROL 1, AND BERICHROM HEPARIN UF CONTROL 2
K083175 · Siemens Healthcare Diagnostics · Jan 2009
STA SATELLITE AUTOMATED MULTI-PARAMETER ANALYZER
K082248 · Diagnostica Stago, Inc. · Dec 2008